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Abstract
Background: Delayed-onset heparin-induced thrombocytopenia with thrombosis, albeit rare, is
a severe side effect of heparin exposure. It can occur within one month after coronary artery
bypass grafting (CABG) with manifestation of different thrombotic events.
Case presentation: A 59-year-old man presented with weakness, malaise, bilateral lower limb
pitting edema and a suspected diagnosis of deep vein thrombosis 18 days after CABG. Heparin
infusion was administered as an anticoagulant. Clinical and paraclinical work-up revealed multiple
thrombotic events (stroke, renal failure, deep vein thrombosis, large clots in heart chambers) and
48 ×103/µl platelet count, whereupon heparin-induced thrombocytopenia was suspected. Heparin
was discontinued immediately and an alternative anticoagulant agent was administered, as a result
of which platelet count recovered. Heparin-induced thrombocytopenia, which causes thrombosis,
is a serious side effect of heparin therapy. It is worthy of note that no case of delayed-onset heparin-
induced thrombocytopenia with thrombosis associated with cardiopulmonary bypass surgery has
thus far been reported in Iran.
Conclusion:  Delayed-onset heparin-induced thrombocytopenia should be suspected in any
patient presenting with arterial or venous thromboembolic disorders after recent heparin therapy,
even though the heparin exposure dates back to more than a week prior to presentation; and it
should be ruled-out before the initiation of heparin therapy.
Background
Heparin-induced thrombocytopenia (HIT) is a severe side
effect of heparin and is associated with heparin-platelet
factor (PF4) antibodies. The incidence of HIT in patients
who have undergone cardiopulmonary bypass surgery has
been estimated at 1.9% [1]. HIT causes not only thrombo-
cytopenia but also arterial and venous thrombotic events
such as lower limb ischemia, stroke, acute myocardial inf-
arction and renal failure [2,3]. The time course to develop-
ment of HIT is generally within 4 to 14 days after the
initiation of heparin therapy.
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Recently, however, it has been shown that HIT can
develop in a delayed fashion, i.e. 1 to 3 weeks after the ces-
sation of heparin [4].
We present a descriptive case of a patient who developed
heparin-induced thrombotic thrombocytopenia (HITT)
18 days after CABG, resulting in multiple arteriovenous
thromboses.
Case history
Our patient, a 59-year-old man with past history of diabe-
tes mellitus and hypertension, presented with signs and
symptoms of acute coronary syndrome for several hours
prior to Cardiac Care Unit (CCU) admission. At CCU, the
patient was diagnosed with acute coronary syndrome, and
drugs including unfractionated heparin (UFH) were
administered. An angiography of his coronary vessels
showed three-vessel disease and a left ventricular ejection
fraction (LVEF) of about 35%.
He underwent CABG urgently with four grafts on his dis-
eased coronary vessels, including left internal mammary
artery graft and 3 saphenous vein grafts. We did not use
any glycoprotein IIb-IIIa receptor antagonist during oper-
ation. The patient was weaned from cardio pulmonary
bypass uneventfully.
During the patient's hospital stay, there were no clinical
features suggestive of HITT or any other abnormalities in
his platelet count and other laboratory tests. He was dis-
charged to his home on the eleventh postoperative day in
good condition with a platelet count of 139 × 10 3/µl,
LVEF of about 35% and normal levels of creatinine and
urea.
One week later (18 days after surgery), the patient
returned to our hospital complaining of weakness,
malaise and bilateral lower limb pitting edema for the
previous two days; he was, subsequently, readmitted to
surgical ward. UFH heparin infusion was commenced
with the diagnosis of deep vein thrombosis (DVT). Work-
up showed a low platelet count of about 48 × 10 3/µl, pro-
longed active partial thromboplastin time of 75 seconds,
DVT of the left lower limb, ejection fraction of about 25–
30% with very large mobile clots in the right atrium (40 ×
20 mm), as well as in the left ventricle and pulmonary
artery (Fig 1, 2). Brain Computerized Tomography scans
showed cortical infarction and deep white matter
ischemia in the right temporoparietal lobe. The patient's
Right atrium (3.99 × 2.57 mm), Right ventricle and left ventricle Clots (3.20 × 2.44 mm) Figure 1
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creatinine and urea levels were about 3.6 mg/dl and 114
mg/dl, respectively. HITT being suspected as the culprit,
heparin infusion was interrupted; and because of the una-
vailability of lepirudin or other alternative anticoagulants,
warfarin was started. Serial lab data showed a gradual rise
in platelet count, and two weeks later his platelet count
and aPTT were within normal ranges.
LVEF was 35% with mild tricuspid regurgitation without
any clotting in the left ventricle, right atrium or pulmo-
nary artery. Pitting edema had decreased, but on account
of the fact that the patient's creatinine level was 3.2 mg/dl,
hemodialysis without heparin was performed so as to
decrease the creatinine level. The patient was discharged
one month after re-admission in good condition with no
clinical signs and symptoms and with disappeared clots
(Fig 3 and 4). Further follow-up of the patient at one year
did not reveal any clinical or paraclinical features sugges-
tive of DVT due to warfarin therapy for HITT [5].
Discussion
HIT (heparin-induced thrombocytopenia) and HITT
(heparin-induced thrombotic thrombocytopenia) are dif-
ferent manifestations of the same immune disease; during
these conditions, the body releases IgG antibody
(immune globulin G) against heparin-PF4 complex.
The incidence of HIT in patients who have undergone car-
diopulmonary bypass surgery has been estimated at 1.9%
[1].
HITT presents with signs and symptoms of the involve-
ment of multi ranges due to vascular thrombosis in those
areas, such as cerebral vascular accidents, myocardial inf-
arction and limb ischemia.
When HITT develops postoperatively, heparin must be
discontinued and alternative anticoagulant agents given.
Alternative anti coagulant agents are intravenous hirudin,
argatroban, danaproid or lepirudin [6-8]. Warfarin is rec-
ommended to start simultaneously with hirudin or other
alternative anticoagulants except heparin. Warfarin is not
contraindicated in treatment of HITT but because of its
potential to make limb gangrene besides of heparin, it is
recommended to administer after other anticoagulant in
HITT [5,8].
Right atrium (3.99 × 2.57 mm), Right ventricle and left ventri- cle Clots (3.20 × 2.44 mm) Figure 2
Right atrium (3.99 × 2.57 mm), Right ventricle and left ventri-
cle Clots (3.20 × 2.44 mm).
echocardiography shows disappearing of clots after treat- ment Figure 3
echocardiography shows disappearing of clots after treat-
ment.
echocardiography shows disappearing of clots after treat- ment Figure 4
echocardiography shows disappearing of clots after treat-
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In our case, the unavailability of alternate anticoagulants
like hirudin obliged us to start only oral warfarin and con-
servative management without platelet transfusion, to
which our patient responded very well.
Diagnosis of HITT is clinical although it must be con-
firmed by serological tests. In our case despite of unavail-
ability of confirmatory tests such as heparin-platelet factor
(PF4) antibodies, typical manifestation of multiorgan
involvement leads us to make diagnosis of HITT.
The time course to development of HIT is generally within
4 to 14 days after the initiation of heparin therapy. None-
theless, it has recently been demonstrated that HIT can
develop in a delayed fashion, i.e. 1 to 3 weeks after the ces-
sation of heparin [4].
Our experience highlights the advisability of the evalua-
tion of any thromboembolic event occurring within 1
month of hospital discharge after CABG for possible
delayed-onset HITT before treatment with heparin.
Overall, it is expedient that the impression of HIT and
HITT after CABG be treated with due sensitivity and that
in cardiac surgical patients the platelet count be carefully
monitored after the operation. A fall of 50% or greater
from the highest postoperative count (with or without
thrombosis) is suggestive of HIT [9].
Conclusion
Delayed-onset HIT should be suspected in any patient
presenting with arterial or venous thromboembolic
thromboembolic disorders after recent heparin therapy,
even though the heparin exposure is more than a week
before representation. Delayed-onset HIT should be con-
sidered and ruled-out before initiating heparin therapy in
this group of patients.
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